← FDA Drug Approvals (Drugs@FDA)

SULFONAMIDES DUPLEX

NDA · New Drug Application · Sponsor: LILLY

Drug application

FDA Application #

NDA006317

Application type

New Drug Application

Brand name

SULFONAMIDES DUPLEX

Generic name

Sulfadiazine

Active ingredients

SULFADIAZINE; SULFAMERAZINE

Dosage form

SUSPENSION

Route

ORAL

Marketing status

Discontinued

Sponsor

LILLY

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown